Potassium binders for the prevention of hyperkalaemia in heart failure patients: Implementation issues and future developments

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

New therapeutic options to treat hyperkalaemia, such as potassium binders, have been suggested as potentially beneficial by allowing the maintenance (or increase) of the dose of medications that improve outcomes in several cardiovascular conditions, but which have in common the propensity for raising serum potassium. However, potassium binding drugs have yet to prove their causal association with improvements in patients' prognosis before their widespread use can be recommended. In this review we provided an up-to-dare appraisal on potassium binders, their potential clinical applications and directions for future research.

Author supplied keywords

Cite

CITATION STYLE

APA

Zannad, F., Ferreira, J. P., & Pitt, B. (2019). Potassium binders for the prevention of hyperkalaemia in heart failure patients: Implementation issues and future developments. European Heart Journal, Supplement, 21, A55–A60. https://doi.org/10.1093/eurheartj/suy034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free